Codes / ICD10CM / C7A.029

C7A.029 Malignant carcinoid tumor of the large intestine, unspecified portion

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Malignant carcinoid tumor of the large intestine, unspecified portion

Summary

A malignant carcinoid tumor of the large intestine, unspecified portion, is a rare neuroendocrine cancer that originates from hormone-producing cells in the large intestine. These tumors may secrete bioactive substances, leading to symptoms related to hormone imbalance or local tissue effects.

Causes

The exact causes of these tumors remain unclear, but they are believed to involve genetic mutations and abnormal growth of neuroendocrine cells. Certain genetic syndromes, such as multiple endocrine neoplasia type 1 (MEN1), may contribute to their development.

Risk Factors

  • Family history of neuroendocrine tumors
  • Genetic conditions such as multiple endocrine neoplasia type 1 (MEN1)
  • Older age
  • History of other gastrointestinal conditions

Symptoms

  • Rectal bleeding or blood in stool
  • Changes in bowel habits (e.g., diarrhea, constipation)
  • Abdominal pain or discomfort
  • Unintended weight loss
  • Carcinoid syndrome (flushing, diarrhea, wheezing) in cases of hormone secretion

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. Blood or urine tests may detect elevated hormone levels (e.g., serotonin or chromogranin A). Imaging studies like CT, MRI, or PET scans help assess tumor spread. Biopsy of the large intestine tissue confirms the diagnosis.

Treatment Options

  • Surgical removal of the tumor or affected portion of the large intestine
  • Chemotherapy or targeted therapy for advanced cases
  • Somatostatin analogs to manage hormone-related symptoms
  • Radiation therapy in select cases

Prognosis and Follow-Up

Prognosis depends on the tumor's stage, size, and whether it has spread. Early detection and treatment improve outcomes. Regular follow-up with imaging and blood tests is recommended to monitor for recurrence or metastasis.

Complications

  • Metastasis to other organs (e.g., liver, lungs)
  • Bowel obstruction
  • Severe carcinoid syndrome
  • Nutritional deficiencies due to malabsorption

Lifestyle & Prevention

  • Maintain a balanced diet to support overall health
  • Avoid smoking and limit alcohol consumption
  • Engage in regular physical activity
  • Attend routine health screenings, especially if at higher risk

When to Seek Professional Help

Seek medical attention if you experience persistent abdominal pain, unexplained weight loss, changes in bowel habits, or symptoms of carcinoid syndrome (e.g., flushing, diarrhea).

Tips for Medical Coders

Use C7A.029 for malignant carcinoid tumors of the large intestine when the specific portion is not documented. Ensure documentation supports the diagnosis and excludes other specified sites (e.g., cecum, rectum) to avoid miscoding. Verify that the tumor is confirmed as malignant and originates from the large intestine.

Book a walkthrough

C7A.029 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.